Who is sponsoring NCT05490420?

NCT05490420 is sponsored by Istanbul Medeniyet University.

What drugs are being tested in NCT05490420?

Interventions in NCT05490420: manual lymphatic drainage (MLD).

What condition does NCT05490420 study?

NCT05490420 studies Carpal Tunnel Syndrome.

Is NCT05490420 still recruiting?

NCT05490420 is currently completed. Last updated 8 September 2023.

Last reviewed 2023-09-08 · How we verify

NCT05490420

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Upper Extremity Manual Lymphatic Drainage on Symptom Severity, Hand Functions, Electrophysiological and Ultrasonographic Measurements in Carpal Tunnel Syndrome

Completed NA Last updated 8 September 2023

What this trial tests

NA trial testing manual lymphatic drainage (MLD) in Carpal Tunnel Syndrome in 27 participants. Completed in 30 July 2023.

Timeline

5 September 2022

Primary endpoint
3 June 2023

30 July 2023

Quick facts

Lead sponsor	Istanbul Medeniyet University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	27
Start date	5 September 2022
Primary completion	3 June 2023
Estimated completion	30 July 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

manual lymphatic drainage (MLD)

Conditions studied

Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →

Sponsor

Istanbul Medeniyet University

Who can join

Adults 40 to 60, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed to investigate the effects of upper extremity manual lymphatic drainage, which is applied to remove edema from the carpal tunnel region in addition to conventional exercise therapy in Carpal tunnel syndrome patients on findings of clinical, ultrasonographic, and electrophysiological.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes · NA · recruiting
NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient · NA · active not recruiting

Other Istanbul Medeniyet University trials

Trials by the same sponsor.

NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05490420 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
Last refreshed: 8 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05490420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing